A well-functioning body is key to overall well-being, and access to evidence-based care empowers people to optimize their health and vitality
Please check our FAQs for further details
While 503B facilities are required to follow current Good Manufacturing Practices (cGMP), the compounded drugs themselves are not FDA-approved. If semaglutide and tirzepatide are removed from the 503B bulks list, the availability of compounded GLP-1s would drop significantly, Michael Snyder, MD, FACS, FASMBS, DABOM, medical director of the Bariatric Surgery Center at Rose Medical Center, founder and director of the Denver Center for Bariatric Surgery Foundation, and in-house obesity specialist at FuturHealth, told MNT
See more No, these are different compounds
Why two words are necessary boils down to the way people communicate about medical treatment